throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`REGENERON PHARMACEUTICALS, INC.
`
`Petitioner,
`
`Vv.
`
`NOVARTIS PHARMAAG,
`NOVARTIS TECHNOLOGYLLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`
`Patent Owners.
`
`
`
`Patent Number: 9,220,631
`
`
`
`DECLARATION OF HORST KOLLER
`
`Regeneron Exhibit 1092.001
`
`Regeneron Exhibit 1092.001
`
`

`

`1.
`
` Thave beenretained by Petitioner Regeneron Pharmaceuticals, Inc.
`
`(“Petitioner” or “Regeneron”), as an independent expert witness in the above-
`
`captionedinter partes review (“IPR”), in which Regeneron has requested that the
`
`U.S. Patent and Trademark Office cancel as unpatentable all claims of U.S. Patent
`
`No. 9,220,631 (“the ’631 patent’).
`
`2.
`
`Myqualifications and compensation are set forth in myoriginal
`
`declaration submitted with Regeneron’s Petition for Inter Partes Review. See Ex.
`
`1003 (Koller Decl.) at {§ 5-17.
`
`3.
`
`I have providedthis supplementaldeclaration to authenticate five
`
`exhibits, Exhibits 1015, 1016, 1052, 1072 and 1074, which are cited in my original
`
`declaration, and for which I understand the Patent Owner has submitted objections.
`
`See Paper 17 (Patent Owner Objections).
`
`4.
`
`Exhibit 1015 is the first volume of a book I reviewed in forming my
`
`opinionsset forth in myoriginal declaration (Ex. 1003). The citation for Exhibit
`
`1015 is Sandeep Nema & John D. Ludwig, Pharmaceutical Dosage Forms:
`
`Parenteral Medications, Volume 1: Formulation and Packaging (3rd ed. 2010).
`
`3:
`
`Exhibit 1016 is the second volumeof the same book. The citation for
`
`Exhibit 1016 is Sandeep Nema & John D. Ludwig, Pharmaceutical Dosage
`
`Forms: Parenteral Medications, Volume 2: Facility Design, Sterilization and
`
`Processing (3rd ed. 2010).
`
`Regeneron Exhibit 1092.002
`
`Regeneron Exhibit 1092.002
`
`

`

`6.
`
`Exhibits 1015 and 1016 are volumesofan authoritative handbook
`
`frequently read, relied upon, and cited by packaging and drug product development
`
`experts such as myself. I have personally reviewed the exhibits and confirmed
`
`they are electronic copies of volumes 1 and 2 of the originally published book.
`
`Te
`
`Exhibit 1052 is a book chapter that I reviewed in forming my opinions
`
`set forth in my original declaration (Ex. 1003). The citation for the chapteris: John
`
`R. Gillis & Gregg Mosley, Validation ofPharmaceutical Process, Chapter 16 —
`
`Validation of Ethylene Oxide Sterilization Processes (2011), pp. 241-262.
`
`8.
`
`Exhibits 1052 is a chapter of an authoritative textbook frequently
`
`read, relied upon, and cited by packaging and drug product development experts
`
`such as myself.
`
`I have personally reviewed the exhibit and confirmedthat it is an
`
`electronic copy ofthe originally published book chapter.
`
`9.
`
`Exhibit 1072 is an article that I reviewed in forming my opinionsset
`
`forth in my original declaration (Ex. 1003). The citation for the article is: Lonny
`
`Wolgemuth, Challenges with Prefilled Syringes: The Parylene Solution,
`
`ONdrugDelivery (Oct. 2012), available at https://ondrugdelivery.com/wp-
`
`content/uploads/201 8/1 1/Oct2012.pdf.
`
`10.
`
`Exhibit 1072 was published in ONdrugDelivery, a medical magazine
`
`that describes itself as being trusted throughout the pharma/biotech industry. The
`
`magazineis frequently read, relied upon, and cited by packaging and drug product
`
`Regeneron Exhibit 1092.003
`
`Regeneron Exhibit 1092.003
`
`

`

`available at
`
`
`
`development experts such as myself. I have personally reviewed the exhibit and
`
`
`
`
`
`
`
`
`
`
`2012 of the October copy of an excerpt confirm that Exhibit 1072 is an electronic
`
`issue that is accessible via the above url.
`
`
`
`in forming my opinions 11. Exhibit 107 4 is another article that I reviewed
`
`
`
`
`
`set forth in my original declaration (Ex. 1003 ). The citation for the article is: SCS
`
`
`
`
`Coating Systems, SCS Parylene Properties (2007),
`https://www.physics.rutgers.edu/~podzorov/parylene%20properties.pdf.
`
`
`
`
`12. Exhibit 1074 was published by SCS Coating Systems, a company
`
`
`
`
`specialized in the development of Parylene. I am familiar with this company and
`
`
`
`
`has reviewed specifications and articles published by them in the past. I have
`
`
`
`
`
`reviewed the exhibit and confirmed that it is an electronic copy of the article that is
`
`accessible via by the above url.
`13. I declare that all statements made herein of my own knowledge are
`
`
`
`
`
`
`
`
`true and that all statements made on information and belief are believed to be true;
`
`
`and further that these statements were made with the knowledge that willful false
`
`
`
`statements and the like so made are punishable by fine or imprisonment, or both,
`
`
`under Section 1001 of Title 18 of the United States Code.
`
`By: _���-� -�-?..-z./' ___ _
`Horst Koller
`
`3
`
`Regeneron Exhibit 1092.004
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket